Literature DB >> 35259455

Friend or foe? Unraveling the complex roles of protein tyrosine phosphatases in cardiac disease and development.

Maike Krenz1.   

Abstract

Regulation of protein tyrosine phosphorylation is critical for most, if not all, fundamental cellular processes. However, we still do not fully understand the complex and tissue-specific roles of protein tyrosine phosphatases in the normal heart or in cardiac pathology. This review compares and contrasts the various roles of protein tyrosine phosphatases known to date in the context of cardiac disease and development. In particular, it will be considered how specific protein tyrosine phosphatases control cardiac hypertrophy and cardiomyocyte contractility, how protein tyrosine phosphatases contribute to or ameliorate injury induced by ischaemia / reperfusion or hypoxia / reoxygenation, and how protein tyrosine phosphatases are involved in normal heart development and congenital heart disease. This review delves into the newest developments and current challenges in the field, and highlights knowledge gaps and emerging opportunities for future research.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac development; Congenital heart disease; Heart failure; Ischaemia / reperfusion; Protein tyrosine phosphatase; Signalling

Mesh:

Substances:

Year:  2022        PMID: 35259455      PMCID: PMC9038168          DOI: 10.1016/j.cellsig.2022.110297

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.850


  125 in total

1.  Principles behind the multifarious control of signal transduction. ERK phosphorylation and kinase/phosphatase control.

Authors:  Jorrit J Hornberg; Frank J Bruggeman; Bernd Binder; Christian R Geest; A J Marjolein Bij de Vaate; Jan Lankelma; Reinhart Heinrich; Hans V Westerhoff
Journal:  FEBS J       Date:  2005-01       Impact factor: 5.542

2.  Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

Authors:  Talita M Marin; Kimberly Keith; Benjamin Davies; David A Conner; Prajna Guha; Demetrios Kalaitzidis; Xue Wu; Jessica Lauriol; Bo Wang; Michael Bauer; Roderick Bronson; Kleber G Franchini; Benjamin G Neel; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

3.  Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1.

Authors:  Anthony J Valente; Tadashi Yoshida; Jason D Gardner; Naveen Somanna; Patrice Delafontaine; Bysani Chandrasekar
Journal:  Cell Signal       Date:  2011-10-20       Impact factor: 4.315

4.  In Silico Analyses Reveal the Relationship Between SIX1/EYA1 Mutations and Conotruncal Heart Defects.

Authors:  Bojian Li; Lijuan Xu; Nanchao Hong; Sun Chen; Rang Xu
Journal:  Pediatr Cardiol       Date:  2017-10-17       Impact factor: 1.655

5.  Simultaneous regulation of apoptotic gene silencing and angiogenic gene expression for myocardial infarction therapy: Single-carrier delivery of SHP-1 siRNA and VEGF-expressing pDNA.

Authors:  Dongkyu Kim; Sook Hee Ku; Hyosuk Kim; Ji Hoon Jeong; Minhyung Lee; Ick Chan Kwon; Donghoon Choi; Sun Hwa Kim
Journal:  J Control Release       Date:  2016-10-18       Impact factor: 9.776

6.  Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis.

Authors:  H F Gu; P Almgren; E Lindholm; L Frittitta; A Pizzuti; V Trischitta; L C Groop
Journal:  Diabetes       Date:  2000-09       Impact factor: 9.461

7.  Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice.

Authors:  Rajinikanth Gogiraju; Marco R Schroeter; Magdalena L Bochenek; Astrid Hubert; Thomas Münzel; Gerd Hasenfuss; Katrin Schäfer
Journal:  Cardiovasc Res       Date:  2016-05-20       Impact factor: 10.787

8.  An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival.

Authors:  Wentian Yang; Lori D Klaman; Binbin Chen; Toshiyuki Araki; Hisashi Harada; Sheila M Thomas; Elizabeth L George; Benjamin G Neel
Journal:  Dev Cell       Date:  2006-03       Impact factor: 12.270

Review 9.  Dual specific phosphatases (DUSPs) in cardiac hypertrophy and failure.

Authors:  Michael Mutlak; Izhak Kehat
Journal:  Cell Signal       Date:  2021-04-29       Impact factor: 4.315

10.  PTPIP51 regulates mouse cardiac ischemia/reperfusion through mediating the mitochondria-SR junction.

Authors:  Xue Qiao; Shi Jia; Jingjing Ye; Xuan Fang; Chenglin Zhang; Yangpo Cao; Chunling Xu; Lifang Zhao; Yi Zhu; Lu Wang; Ming Zheng
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.